These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Experimental study of the therapeutic effect and mechanism of "Shenxian Fuyuan capsule" on chronic renal failure in rats].
    Author: Fu P, He CQ, Liu F, Zhou L, Liu F, Tang WX.
    Journal: Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):430-3, 496. PubMed ID: 16761426.
    Abstract:
    OBJECTIVE: To study the therapeutic effect and mechanism of "Shenxian Fuyuan Capsule" (SXFYC) on chronic renal failure in rats with 5/6 nephrectomy. METHODS: The animal model with chronic renal failure was established by using the method of 5/6 nephrectomy. The animals were randomly divided into four groups: SXFYC treatment group, losartan treatment group, control group and pseudo-operation group (normal group). Since the next day after operations, the rats in the SXFYC treatment group and the losartan treatment group had been intragastrically administrated with SXFYC 300 mg/kg x d and losartan 150 mg/kg x d respectively. The rats in the normal group and control group were fed with sodium chloride twice a day. Four, eight and twelve weeks later, histological and biochemical tests were undertaken to examine changes of the remnant kidney such as alpha-SMA, collagen I, blood urea nitrogen, serum creatinine and proteinuria. The connective tissue growth factor (CTGF) mRNA was detected by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). RESULTS: Both SXFYC and losartan ameliorated the histological change of remnant kidney, decreased the level of CTGF mRNA, serum creatinine and proteinuria (P<0.01). There were no significant differences between the SXFYC and losartan treatment groups (P>0.05). CONCLUSION: "Shenxian Fuyuan Capsule" can improve the renal function of the 5/6 nephrectomized rats. It performs as well as losartan. "Shenxian Fuyuan Capsule" might have played an important role in preventing CTGF-mediated renal fibrosis in the 5/6 nephrectomized rats.
    [Abstract] [Full Text] [Related] [New Search]